Novel nonnucleoside inhibitor of hepatitis C virus RNA-dependent RNA polymerase.
about
High-Affinity Aptamers to Subtype 3a Hepatitis C Virus Polymerase Display Genotypic SpecificityMolecular Mechanism of a Thumb Domain Hepatitis C Virus Nonnucleoside RNA-Dependent RNA Polymerase InhibitorSynergy of a Hepatitis C Virus (HCV) NS4A Antagonist in Combination with HCV Protease and Polymerase InhibitorsMolecular Mechanism of Hepatitis C Virus Replicon Variants with Reduced Susceptibility to a Benzofuran Inhibitor, HCV-796Selected Replicon Variants with Low-Level In Vitro Resistance to the Hepatitis C Virus NS5B Polymerase Inhibitor PSI-6130 Lack Cross-Resistance with R14791,5-Benzodiazepines, a Novel Class of Hepatitis C Virus Polymerase Nonnucleoside InhibitorsSelection and Characterization of Hepatitis C Virus Replicons Dually Resistant to the Polymerase and Protease Inhibitors HCV-796 and Boceprevir (SCH 503034)Slow Binding Inhibition and Mechanism of Resistance of Non-nucleoside Polymerase Inhibitors of Hepatitis C VirusNovel small-molecule inhibitors of hepatitis C virus entry block viral spread and promote viral clearance in cell cultureThe alpha-synuclein 5'untranslated region targeted translation blockers: anti-alpha synuclein efficacy of cardiac glycosides and Posiphen.Assessing evidence from clinical trials in chronic hepatitis C.Genetic diversity of the hepatitis C virus: impact and issues in the antiviral therapy.Recent advances in the development of NS5B polymerase inhibitors for the treatment of hepatitis C virus infection.Antiviral therapy for hepatitis C virus: beyond the standard of care.HCV796: A selective nonstructural protein 5B polymerase inhibitor with potent anti-hepatitis C virus activity in vitro, in mice with chimeric human livers, and in humans infected with hepatitis C virus.A tandem isomerization/prins strategy: iridium(III)/Brønsted acid cooperative catalysisA guided tour through the antiviral drug field
P2860
Q27477457-A23AB103-9280-45A5-A845-E1819234B2ECQ27477757-7DB392A6-53EA-454D-8F9E-23E331CC66B5Q27485893-4650F021-71EB-421C-B2E7-C8B6C6A93BD1Q27486816-E3EEF969-CDBA-4EB9-952F-BE05CBBD422CQ27487389-2801F735-E800-4882-A033-FCF76D60E477Q27487390-0FFB1EAC-A76E-4D84-8E6D-A14FF6715EA8Q27487769-835087C8-E4D9-4EBA-AD82-FE04DDEDDDA9Q27488887-8142D835-DF36-4AB7-B0BB-60C0D8B52E59Q28482494-30549F1C-5B5E-418A-A357-F25CA279C2F9Q33790013-229B13D1-49C3-412C-9844-EED20D7F0AD5Q36455982-3DD222A0-7088-4571-9B31-5073A4E80D73Q36841724-431A8AF6-68BA-42F6-980A-CE182A1680A7Q37481292-6FC649CD-8AB0-4538-B8BD-3ABF0CF2C39DQ37945201-3A4F1917-86E0-4E57-A1E0-F6A19BCA9DE4Q40019405-8D250A5A-4B57-40FC-A763-F6304DE8415FQ41898587-2A5ED210-816D-4A66-B0CD-6215398D21CEQ56786373-640DF457-D3D7-4F3C-8166-DBED85EAD429
P2860
Novel nonnucleoside inhibitor of hepatitis C virus RNA-dependent RNA polymerase.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Novel nonnucleoside inhibitor of hepatitis C virus RNA-dependent RNA polymerase.
@en
Novel nonnucleoside inhibitor of hepatitis C virus RNA-dependent RNA polymerase.
@nl
type
label
Novel nonnucleoside inhibitor of hepatitis C virus RNA-dependent RNA polymerase.
@en
Novel nonnucleoside inhibitor of hepatitis C virus RNA-dependent RNA polymerase.
@nl
prefLabel
Novel nonnucleoside inhibitor of hepatitis C virus RNA-dependent RNA polymerase.
@en
Novel nonnucleoside inhibitor of hepatitis C virus RNA-dependent RNA polymerase.
@nl
P2093
P2860
P1476
Novel nonnucleoside inhibitor of hepatitis C virus RNA-dependent RNA polymerase.
@en
P2093
Alfred Del Vecchio
Anita Y M Howe
Ariamala Gopalsamy
Boris Feld
Carl J Baldick
Christopher A Benetatos
Dorothy C Young
Girija Krisnamurthy
Glen A Coburn
Huiming Cheng
P2860
P304
P356
10.1128/AAC.48.12.4813-4821.2004
P407
P577
2004-12-01T00:00:00Z